Late-breaking data for Roche’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses…
Indonesia seeks to preserve historic railway assets as part of global heritage
Gigawatts Are Announced. Megawatts Must Be Energized.
Noah Kangian Adds 100+ New Services to MSP Panel’s Indian SMM Panel Service List
Astra Security Named Best Autonomous Pentesting Tool of 2026